How is the Crinetics Pharmaceuticals Inc today?

The Crinetics Pharmaceuticals Inc today is trading in the down by -4.53% at 29.95.

What is Crinetics Pharmaceuticals Inc Annual Revenue?

Crinetics Pharmaceuticals Inc Annual Revenue fell 74.11%, in the last year to $1.04 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Crinetics Pharmaceuticals Inc Annual Net Profit?

Crinetics Pharmaceuticals Inc Annual Net Profit fell 39.1% in the last year to $298.41 M. Its sector's average net profit growth for the last fiscal year was -11.04%.

What is Crinetics Pharmaceuticals Inc Price to Earning Ratio?

Crinetics Pharmaceuticals Inc Price to Earning Ratio is -8.55, which is negative.

What is Crinetics Pharmaceuticals Inc Stock Price?

Crinetics Pharmaceuticals Inc Stock Price fell 40.83% and underperformed its sector by 52.16% in the past year.

What is Crinetics Pharmaceuticals Inc Quarterly Revenue?

Crinetics Pharmaceuticals Inc Quarterly Revenue fell 43.59% YoY to $0.36 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Crinetics Pharmaceuticals Inc Quarterly Net profit?

Crinetics Pharmaceuticals Inc Quarterly Net profit fell 44.59% YoY to $96.77 M. Its sector's average net profit growth YoY for the quarter was -212.78%.

What is Crinetics Pharmaceuticals Inc Debt to Equity Ratio?

Crinetics Pharmaceuticals Inc Debt to Equity Ratio of 0.04 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Crinetics Pharmaceuticals Inc Return on Equity(ROE)?

Crinetics Pharmaceuticals Inc Return on Equity(ROE) for the last financial year was -32.02%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Crinetics Pharmaceuticals Inc Mutual Fund Holding?

Crinetics Pharmaceuticals Inc Mutual Fund Holding decreased by 0.06% in the last quarter to 82.37.

What is Crinetics Pharmaceuticals Inc Promoter Share Holding?

Crinetics Pharmaceuticals Inc Promoter Share Holding increased by 0.04% in the most recent quarter to 3.4%.

What is Crinetics Pharmaceuticals Inc Institutional Holding?

Crinetics Pharmaceuticals Inc Institutional Holding increased by 4.37% in the last quarter to 111.43.

Crinetics Pharmaceuticals Inc XNAS: CRNX

Crinetics Pharmaceuticals Inc Live Share Price Today, Share Analysis and Chart

Name: Crinetics Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Crinetics Pharmaceuticals Inc
Rating: 0.82258325
Author: Trendlyne DVM scores

about

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and...

29.95 -1.42 (-4.53%)

52.10% Fall from 52W High

668.1K XNAS Volume

XNAS 21 May, 2025 5:30 PM (EDT)

Not Eligible

-

Expensive Valuation

7.3 / 100

Technically Bearish

25.6 / 100

73

1Yr Price target upside is 143%

15 analysts

Crinetics Pharmaceuticals Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Crinetics Pharmaceuticals Inc FAQ

How is Crinetics Pharmaceuticals Inc today?

Crinetics Pharmaceuticals Inc today is trading in the red, and is down by -4.53% at 29.95.

How has Crinetics Pharmaceuticals Inc performed historically?

Crinetics Pharmaceuticals Inc is currently trading down -4.53% on an intraday basis. In the past week the stock fell -3.23%. stock has been down -18.75% in the past quarter and fell -40.83% in the past year. You can view this in the overview section.